CBD Life Sciences Inc. (OTCMKTS: CBDL) is making a powerful run up the charts in recent weeks skyrocketing out of the triple zeroes and emerging as a volume leader in small caps topping 1 billion shares traded last Friday. CBDL through its wholly owned subsidiary LBC Bioscience Inc. manufactures and sells a full line of CBD products with now over 50 individual products and growing fast. LBC is catching on with the Company recently reporting sales of $120,950 for the 3 months ended September 30, 2020 up from $11k in Q3 2019 and they are virtually debt free with just $149k in liabilities meaning little or no dilution. Penny stock speculators are quickly catching on to the CBDL story and are bidding the stock higher in recent trading.
Marijuana and CBD stocks are on the rise in recent months as New Jersey, Arizona, Montana and South Dakota legalize cannabis for recreational use. Also the house just passed sweeping legislation that would decriminalize marijuana and expunge nonviolent marijuana-related convictions although the bill is unlikely to pass. CBD is booming and is projected to reach $4.7 billion in US sales in 2020 up from $4.1 billion in 2019. According to a new reported from reserchandmarkets.com; The U.S. cannabidiol market is estimated to reach US$13.39 billion in 2024, growing at a CAGR of 42.36% for the period spanning 2020-2024.
CBD Life Sciences Inc. (OTCMKTS: CBDL) operating out of Scottsdale, Arizona through its wholly owned subsidiary LBC Bioscience Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL’. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The Company has been through several incarnations most recently named Cre8tive Works; in the business of financing media production. On January 1, 2019, the name was changed to CBD Life Sciences, Inc. through a share exchange to capitalize on the growing cannabidiol sector.
The Company’s wholly owned subsidiary LBC Bioscience Inc. has developed and is retailing/wholesaling a full line of cannabidiol based organic products including CBD drops, pain relief creams, anxiety and sleep supplements, CBD brain boost coffee, weight loss coffee, gummies, a full line of CBD infused anti – aging skincare line and a full pet line including Hemp for horses. Principal Products of the company is an array of high-quality line of organic cannabidiol based supplements and wellness products. Why Shop LBC Bioscience? Free Shipping on All Orders for the Holidays; Large Selection of Products (over 50 items and growing); 100% USA Made Products “organic & kosher”; 30% off on all products through the Holidays using code “LBC30” A listing of some of the Company’s products follows:
CBD Rich Hemp Oil Drops-relief of acne, arthritis, anxiety, chronic pain, depression.
CBD Hemp Oil Anxiety E Liquid-formulated to aid reduce anxiety.
CBD Hemp Oil Sleep E Liquid-formulated to induce sleep.
CBD Vitamin B12 Drops-increases energy.
CBD Biotin Drops promotes healthy skin, hair and nails.
CBD Garcinia Cambogia Drops suppresses appetite supporting weight loss and breaks down fat.
CDB Terpenes & Tincutres-taken for acne, arthritis, anxiety, chronic pain, depression, pain relief
CBD Gummy Bears pain relief, anti-inflammatory, stress and anxiety relief
CBD Pain Relief Cream minor muscle and joint pain
CDD Freeze Pain Cold Rub topical analgesic blended with raw
CBD to soother minor aches and pains
CBD Pet supplement Drops treats arthritis and digestive issues
CBD Pet Treats assists with reduction in arthritis, stress and digestive issues
CBD Pain Cream for Pets topical solution for arthritis and acute strains or torn ligaments.
To Find out the inside Scoop on CBDL Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Earlier this year CBDL announced its CBD Kiosk is now open at Fashion Square Mall! The Kiosk is in a prime location right near Tesla & Microsoft. Fashion Square Mall is based in the heart of Scottsdale, AZ and has Arizona’s largest selection of Exclusive Stores & Brands. Close by the Mall is Old Town Scottsdale, which is a popular tourist destination that brings in an immensely amount of revenue. The Company had initially planned to open the kiosk earlier but due to Covid-19 it was held back. The CBD Kiosk is selling the Company’s full line of CBD products such as Pain Relief Creams, Hand Sanitizers, Pet Products, Gummy Bears, Tablets, Skincare Products, Drops, Coffee, Honey Sticks & more. For the full line of CBDL products go here: https://www.lbcbioscienceinc.com/shop
On December 3 CBDL wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announced today that the company will be introducing a new product. This product is CBD Flower along with two tasty flavors. One strain we are going to be working with is called Hawaiian Haze that is said to remind people of a blissful Hawaiian getaway. This strain of CBD is known to give of the tropical hints of pineapple, mango, Lemon and even a slight hint of chamomile. It has a strong terpene profile of myrcene and beta-caryophyllene. Hawaiian haze is great for social events or daytime use. Because of this full-spectrum products impressive terpene profile, users can feel confident to get the results they desire punctually. Another strain we are working with is known as Sour Space Candy that originates from Oregon. This strain has an exclusive flavor profile of candied apple with a sour kick. As far as the taste of this strain goes, this beautiful masculine formed strain stays true to its name and tastes of sweet candy apples that bounces nicely with a slight cherry flavor hint. Being this impressive, users have given this flower high praise mainly for the smell and taste.
CEO, Lisa Nelson stated on the benefits of CBD; “These benefits include help with behavioral/neurological complications such as ADD/ADHD, anxiety, bipolar, OCD, PTSD, epilepsy, Parkinson’s, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn’s, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.”
LBC Bioscience Inc. is well stocked with some very high-quality CBD offerings – all at very reasonable prices with its Holiday Specials. Check out LBC Bioscience Inc’s newest product offerings including its: 100mg CBD Bath Bombs in a variety of scents with Holiday Scents coming within the next few weeks. 1500 MG Premium Berry Drops, 100MG CBD Tablets and our tasty CBD Gumballs. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
$CBDL with such a big volume, those *820M notes already also consumed by the market, I see a continuation next week pic.twitter.com/KXAOCUMwcz
— PAPAstocks (@papastocks001) December 4, 2020
For More on CBDL Subscribe Right Now!
CBDL is making a powerful run up the charts in recent weeks skyrocketing out of the triple zeroes and emerging as a volume leader in small caps topping 1 billion shares traded last Friday. CBDL through its wholly owned subsidiary LBC Bioscience Inc. manufactures and sells a full line of CBD products with now over 50 individual products and growing fast. RBL is catching on with the Company recently reporting sales of $120,950 for the 3 months ended September 30, 2020 up from $11k in Q3 2019 and they are virtually debt free with just $149k in liabilities meaning little or no dilution. Penny stock speculators are quickly catching on to the CBDL story and are bidding the stock higher in recent trading. CBD is booming and is projected to reach $4.7 billion in US sales in 2020 up from $4.1 billion in 2019. According to a new reported from reserchandmarkets.com; The U.S. cannabidiol market is estimated to reach US$13.39 billion in 2024, growing at a CAGR of 42.36% for the period spanning 2020-2024. We will be updating on CBDL when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CBDL.
Disclosure: we hold no position in CBDL either long or short and we have not been compensated for this article.